References
- Garagnani P, Pirazzini C, Franceschi C. Colorectal cancer microenvironment: among nutrition, gut microbiota, inflammation and epigenetics. Curr Pharm Des. 2013;19(4):765–778. doi:https://doi.org/10.2174/138161213804581981
- Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol. 2014;20(24):7878–7886. doi:https://doi.org/10.3748/wjg.v20.i24.7878
- Tilg H, Adolph TE, Gerner RR, Moschen AR. Moschen: the intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33(6):954–964. doi:https://doi.org/10.1016/j.ccell.2018.03.004
- Wu Y, Wu J, Chen T, Li Q, Peng W, Li H, Tang X, Fu X. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade. Dig Dis Sci. 2018;63(5):1210–1218. doi:https://doi.org/10.1007/s10620-018-4999-2
- Nguyen DD, Muthupalani S, Goettel JA, Eston MA, Mobley M, Taylor NS, McCabe A, Marin R, Snapper SB, Fox JG. Colitis and colon cancer in WASP-deficient mice require helicobacter species. Inflamm Bowel Dis. 2013;19:2041–2050.
- Zhu Y, Luo TM, Jobin C, Young HA. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett. 2011;309(2):119–127. doi:https://doi.org/10.1016/j.canlet.2011.06.004
- Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik RB-Z, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174(6):1388–1405.e21. doi:https://doi.org/10.1016/j.cell.2018.08.041
- De Almeida CV, Lulli M, di Pilato V, Schiavone N, Russo E, Nannini G, Baldi S, Borrelli R, Bartolucci G, Menicatti M, et al. Differential responses of colorectal cancer cell lines to enterococcus faecalis’ strains isolated from healthy donors and colorectal cancer patients. JCM. 2019;8(3):388. doi:https://doi.org/10.3390/jcm8030388
- De Marco S, Sichetti M, Muradyan D, Piccioni M, Traina G, Pagiotti R, Pietrella D. Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS. Evid Based Complement Alternat Med. 2018;2018:1756308. doi:https://doi.org/10.1155/2018/1756308
- Han KJ, Lee NK, Park H, Paik HD. Anticancer and anti-inflammatory activity of probiotic Lactococcus lactis NK34. J Microbiol Biotechnol. 2015;25(10):1697–1701. doi:https://doi.org/10.4014/jmb.1503.03033
- Gilliland SE. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev. 1990;7(1–2):175–188. doi:https://doi.org/10.1111/j.1574-6968.1990.tb04887.x
- Kim JY, Woo HJ, Kim YS, Kim KH, Lee HJ. Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp lactis in SNUC2A, a colon cancer cell line. Nutr Cancer. 2003;46(2):197–201. doi:https://doi.org/10.1207/S15327914NC4602_13
- Masood MI, Qadir MI, Shirazi JH, Khan IU. Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol. 2011;37(1):91–98. doi:https://doi.org/10.3109/1040841X.2010.536522
- Martinez-Jaramillo E, Garza-Morales R, Loera-Arias MJ, Saucedo-Cardenas O, Montes-de-Oca-Luna R, McNally LR, Gomez-Gutierrez JG. Development of Lactococcus lactis encoding fluorescent proteins, GFP, mCherry and iRFP regulated by the nisin-controlled gene expression system. Biotech Histochem. 2017;92(3):167–174. doi:https://doi.org/10.1080/10520295.2017.1289554
- Miks-Krajnik M, Babuchowski A. 16S rRNA-targeted oligonucleotide probes for direct detection of Propionibacterium freudenreichii in presence of Lactococcus lactis with multicolour fluorescence in situ hybridization. Lett Appl Microbiol. 2014;59(3):320–327. doi:https://doi.org/10.1111/lam.12278
- Del Carmen S, de Moreno de LeBlanc A, Levit R, Azevedo V, Langella P, Bermudez-Humaran LG, LeBlanc JG. Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model. Int Immunopharmacol. 2017;42:122–129. doi:https://doi.org/10.1016/j.intimp.2016.11.017
- Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG. Bermudez-Humaran: effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother. 2014;10(6):1611–1621. doi:https://doi.org/10.4161/hv.28549
- Halama N, Braun M, Kahlert C, Spille A, Quack C, Rahbari N, Koch M, Weitz J, Kloor M, Zoernig I, et al. Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res. 2011;17(4):678–689. doi:https://doi.org/10.1158/1078-0432.CCR-10-2173
- Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503–510. doi:https://doi.org/10.1038/ni1582
- Yamane T, Sakamoto T, Nakagaki T, Nakano Y. Lactic acid bacteria from kefir increase cytotoxicity of natural killer cells to tumor cells. Foods. 2018;7(4):48. doi:https://doi.org/10.3390/foods7040048
- Yu J, Chen Y, Fu X, Zhou X, Peng Y, Shi L, Chen T, Wu Y. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int J Cancer. 2016;139(6):1318–1326. doi:https://doi.org/10.1002/ijc.30168
- Ercolini D, Hill PJ, Dodd CE. Bacterial community structure and location in Stilton cheese. Appl Environ Microbiol. 2003;69(6):3540–3548. doi:https://doi.org/10.1128/AEM.69.6.3540-3548.2003
- de Moreno de LeBlanc A, LeBlanc JG, Perdigon G, Miyoshi A, Langella P, Azevedo V, Sesma F. Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J Med Microbiol. 2008;57(Pt 1):100–105. doi:https://doi.org/10.1099/jmm.0.47403-0
- de Moreno de LeBlanc A, Del Carmen S, Chatel JM, Miyoshi A, Azevedo V, Langella P, Bermudez-Humaran LG, LeBlanc JG. Current review of genetically modified lactic acid bacteria for the prevention and treatment of colitis using murine models. Gastroenterol Res Pract. 2015;2015:146972. doi:https://doi.org/10.1155/2015/146972
- Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, Joo HG, Woo HJ. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci. 2004;5(1):41–48. doi:https://doi.org/10.4142/jvs.2004.5.1.41
- Wei Z, Cao S, Liu S, Yao Z, Sun T, Li Y, Li J, Zhang D, Zhou Y. Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients’ survival? A pilot study on relevant mechanism. Oncotarget. 2016;7(29):46158–46172. doi:https://doi.org/10.18632/oncotarget.10064
- Wu Y, Shi L, Li Q, Wu J, Peng W, Li H, Chen K, Ren Y, Fu X. Microbiota diversity in human colorectal cancer tissues is associated with clinicopathological features. Nutr Cancer. 2019;71(2):214–222. doi:https://doi.org/10.1080/01635581.2019.1578394
- O’Toole PW. Changes in the intestinal microbiota from adulthood through to old age. Clin Microbiol Infect. 2012;18(Suppl 4):44–46. doi:https://doi.org/10.1111/j.1469-0691.2012.03867.x
- Saunier K, Dore J. Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis. 2002;34(Suppl 2):S19–S24. doi:https://doi.org/10.1016/S1590-8658(02)80158-X
- Hopkins MJ, Sharp R, Macfarlane GT. Variation in human intestinal microbiota with age. Dig Liver Dis. 2002;34(Suppl 2):S12–S18. doi:https://doi.org/10.1016/S1590-8658(02)80157-8
- Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011;121(9):3609–3622. doi:https://doi.org/10.1172/JCI45816
- Peng YP, Zhu Y, Zhang JJ, Xu ZK, Qian ZY, Dai CC, Jiang KR, Wu JL, Gao WT, Li Q, et al. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J Transl Med. 2013;11:262. doi:https://doi.org/10.1186/1479-5876-11-262
- Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, Marcenaro E, Accame L, Malaspina A, Biassoni R, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999;190(10):1505–1516. doi:https://doi.org/10.1084/jem.190.10.1505
- Jounai K, Sugimura T, Morita Y, Ohshio K, Fujiwara D. Administration of Lactococcus lactis strain Plasma induces maturation of plasmacytoid dendritic cells and protection from rotavirus infection in suckling mice. Int Immunopharmacol. 2018;56:205–211. doi:https://doi.org/10.1016/j.intimp.2018.01.034
- Suzuki H, Jounai K, Ohshio K, Fujii T, Fujiwara D. Administration of plasmacytoid dendritic cell-stimulative lactic acid bacteria enhances antigen-specific immune responses. Biochem Biophys Res Commun. 2018;503(3):1315–1321. doi:https://doi.org/10.1016/j.bbrc.2018.07.042
- Suzuki H, Ohshio K, Fujiwara D. Lactococcus lactis subsp. lactis JCM 5805 activates natural killer cells via dendritic cells. Biosci Biotechnol Biochem. 2016;80(4):798–800. doi:https://doi.org/10.1080/09168451.2015.1116922